selected scholarly activity
-
chapters
- Infectious disease. 300-306. 2013
- Heroin Addiction. 657-667. 2013
- Chapter 67 Heroin Addiction. 657-667. 2013
- Heroin Addiction. 657-667. 2013
- Alcohol-Related Seizure Disorders. 144-154. 2012
- Epidemiology of Alcohol Abuse: Extent and Nature of the Problem. 99-123. 2009
-
conferences
- Early Outcomes of Repetitive Transcranial Magnetic Stimulation in Complex Clinical Population. European psychiatry. S158-S159. 2023
- Measurement-Based Care in Treatment of Substance Use Disorders. European psychiatry. S614-S615. 2022
- Theory and Practice of Treatment of Concurrent Major Depressive and Alcohol Use Disorders. European psychiatry. S455-S455. 2022
- Food addiction in a large non-clinical sample of Canadians. European psychiatry. S826-S826. 2021
- Changes in patient satisfaction questionnaire responses following the modification of the program delivery to group-based didactic treatment approach.. European psychiatry. S512-S512. 2020
- Transdiagnostic assessment of clinical outcomes in the comprehensive psychiatric care unit: do changes in service delivery model always mean improvement?. European psychiatry. S224-S224. 2020
- Quality of life in patients seeking treatment for alcohol use disorder and concurrent disorders in Ontario, Canada. European psychiatry. S581-S582. 2019
- Reversing opioid-induced constipation in methadone users with oral naloxone: clinically meaningful placebo effect?. European psychiatry. S367-S368. 2019
- Clinical outcomes of the DA VINCI (Depression and Alcoholism: Validation of an Integrated Care Initiative) Project. European psychiatry. S157-S157. 2018
- Triple-blind randomized placebo-controlled clinical trial of oral naloxone for opioid-induced constipation in patients with opioid use disorder receiving methadone maintenance treatment. European psychiatry. S318-S318. 2018
- CLINICAL OUTCOMES OF THE INTEGRATED CARE PATHWAY FOR CONCURRENT MAJOR DEPRESSIVE AND ALCOHOL USE DISORDERS: A REVIEW OF THE FIRST TWO YEARS. Alcoholism: Clinical and Experimental Research. 230A-230A. 2017
- Tailoring knowledge in evidence based medicine: incorporating patient values and preferences into knowledge tools. Implementation Science. 2017
- Clinical Outcomes of the First 2 Years of Implementation of the Integrated Care Pathway for Concurrent Major Depressive Disorder and Alcohol Use Disorder. European psychiatry. S79-S79. 2017
- EFFECTS OF NALTREXONE ON ALCOHOL SELF-ADMINISTRATION AND CRAVING: META-ANALYSIS OF HUMAN LABORATORY STUDIES. Alcoholism: Clinical and Experimental Research. 164A-164A. 2016
- Early Outcomes of the Integrated Care Pathway for Concurrent Major Depressive Disorder and Alcohol Dependence. European psychiatry. 1088-1088. 2015
- Oral Naloxone for Methadone-induced Constipation: Preliminary Results of a Randomized Placebo-controlled Trial. European psychiatry. 1919-1919. 2015
-
journal articles
- Using Measurement-Based Care as a Precision Medicine Strategy for Substance Use Disorders. Current Psychiatry Reports. 26:215-221. 2024
- Using Latent Profile Analysis to Characterize Clinical Heterogeneity and Impulsivity in a Large Residential Addiction Treatment Program. Substance Use and Misuse. 59:1-10. 2024
- Combined effect of alcohol and cannabis on simulated driving. Psychopharmacology. 239:1263-1277. 2022
- Integrating a brief alcohol intervention with tobacco addiction treatment in primary care: qualitative study of health care practitioner perceptions. Addiction Science & Clinical Practice. 16:17. 2021
- Food addiction in a large community sample of Canadian adults: prevalence and relationship with obesity, body composition, quality of life and impulsivity. Addiction. 116:2870-2879. 2021
- Theory and Practice of Treatment of Concurrent Major Depressive and Alcohol Use Disorders: 7 Lessons from Clinical Practice and Research. Canadian Journal of Addiction. 12:39-46. 2021
- Optimizing screening for depression, anxiety disorders, and post-traumatic stress disorder in inpatient addiction treatment: A preliminary investigation. Addictive Behaviors. 112:106649-106649. 2021
- Personalized dosing of nicotine replacement therapy versus standard dosing for the treatment of individuals with tobacco dependence: study protocol for a randomized placebo-controlled trial. Trials. 21:592. 2020
- Predictors of premature treatment termination in a large residential addiction medicine program. Journal of Substance Use and Addiction Treatment. 117:108077-108077. 2020
- Brief Interventions for Cannabis Use in Healthcare Settings: Systematic Review and Meta-analyses of Randomized Trials. Journal of Addiction Medicine. 14:78-88. 2020
- The effect of a clinical decision support system on prompting an intervention for risky alcohol use in a primary care smoking cessation program: a cluster randomized trial. Implementation Science. 14:85. 2019
- A method for co-creation of an evidence-based patient workbook to address alcohol use when quitting smoking in primary care: a case study. Research Involvement and Engagement. 4:4. 2018
- Outcomes of an integrated care pathway for concurrent major depressive and alcohol use disorders: a multisite prospective cohort study. BMC Psychiatry. 18:189. 2018
- Trends in treatment of problematic cannabis use in Ontario’s specialized addiction treatment system from 2010/11 to 2015/16: a repeated cross-sectional study of a health administrative database. CMAJ open. 6:E495-E501. 2018
- Glass-Box Testing the Centre for Addiction and Mental Health Integrated Care Pathway for Major Depressive and Alcohol Use Disorders: Is It More Than a Sum of Its Components?. Canadian Journal of Addiction. 9:7-17. 2018
- Combining alcohol interventions with tobacco addictions treatment in primary care—the COMBAT study: a pragmatic cluster randomized trial. Implementation Science. 12:65. 2017
- Effects of naltrexone on alcohol self‐administration and craving: meta‐analysis of human laboratory studies. Addiction Biology. 22:1515-1527. 2017
- Integrated care pathway for co-occurring major depressive and alcohol use disorders: Outcomes of the first two years. American Journal on Addictions. 26:602-609. 2017
- Management of mood and anxiety disorders in patients receiving opioid agonist therapy: Review and meta-analysis. American Journal on Addictions. 26:551-563. 2017
- The contribution of unrecorded alcohol to health harm. Addiction. 112:1687-1688. 2017
- Alcohol consumption as a risk factor for tuberculosis: meta-analyses and burden of disease. European Respiratory Journal. 50:1700216-1700216. 2017
- The relationship between different dimensions of alcohol use and the burden of disease—an update. Addiction. 112:968-1001. 2017
- Proceedings from the 9th annual conference on the science of dissemination and implementation. Implementation Science. 12:48. 2017
- A 35-year-old woman with low mood and concerns about her alcohol use. CANADIAN MEDICAL ASSOCIATION JOURNAL. 189:E317-E318. 2017
- Alcohol Consumption as a Risk Factor for Acute and Chronic Pancreatitis: A Systematic Review and a Series of Meta-analyses. EBioMedicine. 2:1996-2002. 2015
- Development and Implementation of an Ambulatory Integrated Care Pathway for Major Depressive Disorder and Alcohol Dependence. Psychiatric Services. 66:1265-1267. 2015
- Opioid-induced constipation reversal in response to placebo in a patient with a history of IBS receiving methadone maintenance therapy. BMJ Case Reports. 2015:bcr2015211954-bcr2015211954. 2015
- Smokers who seek help in specialized cessation clinics: How special are they compared to smokers in general population?. Journal of Smoking Cessation. 9:76-84. 2014
- A systematic review of the epidemiology of unrecorded alcohol consumption and the chemical composition of unrecorded alcohol. Addiction. 109:880-893. 2014
- Premature mortality in patients with epilepsy. The Lancet. 383:511-511. 2014
- The Tangible Common Denominator of Substance Use Disorders: A Reply to Commentaries to Rehm et al. (2013a). Alcohol and alcoholism (Oxford, Oxfordshire). Supplement. 49:118-122. 2014
- Tobacco retail availability and smoking behaviours among patients seeking treatment at a nicotine dependence treatment clinic. Tobacco Induced Diseases. 12:19-19. 2014
- Defining Substance Use Disorders: Do We Really Need More Than Heavy Use?. Alcohol and alcoholism (Oxford, Oxfordshire). Supplement. 48:633-640. 2013
- Naltrexone may block euphoria-like placebo effect. BMJ Case Reports. 2013:bcr2013010098-bcr2013010098. 2013
- Global burden of alcoholic liver diseases. Journal of Hepatology. 59:160-168. 2013
- Phenibut dependence. BMJ Case Reports. 2013:bcr2012008381-bcr2012008381. 2013
- Causality between polyhexamethyleneguanidine occurrence in unrecorded alcohol and cholestatic hepatitis outbreak in Russia. Clinical Toxicology. 50:154-155. 2012
- Unrecorded alcohol consumption in Russia: toxic denaturants and disinfectants pose additional risks. Interdisciplinary Toxicology. 4:198-205. 2011
- Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis. European Journal of Preventive Cardiology (EJPC). 17:706-712. 2010
- Alcohol consumption as a risk factor for pneumonia: a systematic review and meta-analysis. Epidemiology and Infection. 138:1789-1795. 2010
- Disability Associated With Alcohol Abuse and Dependence. Alcoholism: Clinical and Experimental Research. 34:1871-1878. 2010
- The composition of unrecorded alcohol from eastern Ukraine: Is there a toxicological concern beyond ethanol alone?. Food and Chemical Toxicology. 48:2842-2847. 2010
- Alcohol consumption, unprovoked seizures, and epilepsy: A systematic review and meta‐analysis. Epilepsia. 51:1177-1184. 2010
- The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction. 105:817-843. 2010
- The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health. 9:450. 2009
- Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis.. Journal of the Pancreas. 10:387-392. 2009
- Alcohol use and addiction services in Ukraine. BJPsych International. 6:5-7. 2009
- Feasibility and Outcomes of a Community-Based Taper-to-Low- Dose-Maintenance Suboxone Treatment Program for Prescription Opioid Dependence in a Remote First Nations Community in Northern Ontario. Journal of Aboriginal Health. 9:52-59.
- Global burden of tuberculosis and lower respiratory infections attributable to alcohol consumption in 2004. International Journal of Alcohol and Drug Research. 2:11-18.
- Global burden of tuberculosis and lower respiratory infections attributable to alcohol consumption in 2004. International Journal of Alcohol and Drug Research. 2.
-
preprints